When appropriate, tapering the medication under a clinician's guidance can make the transition less jarring
These dual agonists, such as tirzepatide (a GIP/GLP-1 dual agonist), are emerging as promising treatments for T2DM due to their superior effects on blood glucose control and weight loss compared to traditional single agonists
GLP-1 receptor agonists are synthetic molecules that mimic the binding of glucagon-like peptide-1 (GLP-1), a hormone that helps our bodies regulate metabolism and appetite
It is a powerful tool for making informed timing decisions rather than guessing
In fact, of the nearly half a million adults on GLP-1s, more than 60% consume below estimated requirements for calcium and iron and vitamin D intake averaged just 20% of recommendations, according to a 2026 narrative review in Clinical Obesity
If you have any questions, contact Pearl Taylor, HEDIS Coordinator, at 215-991-4283 or our Provider Services Helpline at 1-888-991-9023 (Monday-Friday, 9:00 a.m